{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "clinical", "critically-ill", "intensive care unit", "major ozonated autohemotherapy", "mechanical ventilation", "paraclinical", "supportive care"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "37929510", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "07"}, "DateRevised": {"Year": "2023", "Month": "12", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": ["10.4103/2045-9912.385439"], "Journal": {"ISSN": "2045-9912", "JournalIssue": {"Volume": "14", "Issue": "2", "PubDate": {"Year": "2024", "Season": "Apr-Jun"}}, "Title": "Medical gas research", "ISOAbbreviation": "Med Gas Res"}, "ArticleTitle": "Effects of adjuvant ozone autohemotherapy combined with routine treatment on clinical and paraclinical features of mechanically ventilated COVID-19 patients in the intensive care unit: a pilot randomized controlled trial.", "Pagination": {"StartPage": "67", "EndPage": "74", "MedlinePgn": "67-74"}, "Abstract": {"AbstractText": ["Until the availability of an effective and practical vaccine, there is a serious need to recognize alternative treatments for coronavirus disease 2019 (COVID-19). This study aimed to determine whether major ozonated autohemotherapy (MOAH) can improve the clinical and paraclinical parameters in critically-ill patients with COVID-19 requiring mechanical ventilation. In this controlled trial, we enrolled 40 critically ill COVID-19 patients receiving invasive mechanical ventilation. The enrolled patients were then randomized into the MOAH and control groups. The patients in the MOAH group received MOAH three times per week (10 times in total) in addition to routine treatment and standard critical supportive care. Patients in the control group were only given regular treatment and standard critical supportive care. The patients in the MOAH group had more days of breathing with no aid than those in the control group. Moreover, the length of stay in the intensive-care unit was significantly lower in the MOAH group than in the control group. MOAH resulted in higher ventilation-free days and less intensive-care unit stay compared with the control treatment. In COVID-19 patients undergoing mechanical ventilation, MOAH with routine treatment resulted in more ventilator-free days and less intensive-care unit stay compared with the standard therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Palliative Care Medicine Department, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Aghamohammadi", "ForeName": "Dawood", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Shakouri", "ForeName": "Seyed Kazem", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Jahanpanah", "ForeName": "Negar", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences, Tabriz, Iran."}], "LastName": "Dolatkhah", "ForeName": "Neda", "Initials": "N"}], "PublicationTypeList": ["Randomized Controlled Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Med Gas Res", "NlmUniqueID": "101564536", "ISSNLinking": "2045-9912"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapy"], "DescriptorName": "COVID-19"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Respiration, Artificial"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": [], "DescriptorName": "Intensive Care Units"}], "CoiStatement": "\n<b>Conflicts of interest</b>\n. None declared."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239\u20131242.", "ArticleIdList": ["32091533"]}, {"Citation": "Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u2013513.", "ArticleIdList": ["PMC7135076", "32007143"]}, {"Citation": "Amani B, Amani B, Zareei S, Zareei M. Efficacy and safety of arbidol (umifenovir) in patients with COVID-19: A systematic review and meta-analysis. Immun Inflamm Dis. 2021;9:1197\u20131208.", "ArticleIdList": ["PMC8426686", "34347937"]}, {"Citation": "Elsawah HK, Elsokary MA, Abdallah MS, ElShafie AH. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis. Rev Med Virol. 2021;31:e2187.", "ArticleIdList": ["33128490"]}, {"Citation": "Verdugo-Paiva F, Izcovich A, Ragusa M, Rada G. Lopinavir-ritonavir for COVID-19: A living systematic review. Medwave. 2020;20:e7967.", "ArticleIdList": ["32678815"]}, {"Citation": "Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386:1397\u20131408.", "ArticleIdList": ["PMC8908851", "35172054"]}, {"Citation": "Lythgoe MP, Rhodes CJ, Ghataorhe P, Attard M, Wharton J, Wilkins MR. Why drugs fail in clinical trials in pulmonary arterial hypertension, and strategies to succeed in the future. Pharmacol Ther. 2016;164:195\u2013203.", "ArticleIdList": ["27133570"]}, {"Citation": "Hotchkiss RS, Opal SM. Activating immunity to fight a foe - a new path. N Engl J Med. 2020;382:1270\u20131272.", "ArticleIdList": ["PMC8025910", "32212525"]}, {"Citation": "Viebahn-Haensler R. Milestones of medical ozone. Rev Soc Esp Dolor. 2005;12:S3\u20139."}, {"Citation": "Wu XN, Zhang T, Wang J, et al. Magnetic resonance diffusion tensor imaging following major ozonated autohemotherapy for treatment of acute cerebral infarction. Neural Regen Res. 2016;11:1115\u20131121.", "ArticleIdList": ["PMC4994454", "27630695"]}, {"Citation": "Molinari F, Simonetti V, Franzini M, et al. Ozone autohemotherapy induces long-term cerebral metabolic changes in multiple sclerosis patients. Int J Immunopathol Pharmacol. 2014;27:379\u2013389.", "ArticleIdList": ["25280029"]}, {"Citation": "Zaky S, Kamel SE, Hassan MS, et al. Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. J Altern Complement Med. 2011;17:259\u2013263.", "ArticleIdList": ["21417811"]}, {"Citation": "Ripamonti CI, Cislaghi E, Mariani L, Maniezzo M. Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study. Oral Oncol. 2011;47:185\u2013190.", "ArticleIdList": ["21310650"]}, {"Citation": "Wu X, Li Z, Liu X, et al. Major ozonated autohemotherapy promotes the recovery of upper limb motor function in patients with acute cerebral infarction. Neural Regen Res. 2013;8:461\u2013468.", "ArticleIdList": ["PMC4146136", "25206688"]}, {"Citation": "Foglieni C, Fulgenzi A, Belloni D, Sciorati C, Ferrero E, Ferrero ME. Ozonated autohemotherapy: protection of kidneys from ischemia in rats subjected to unilateral nephrectomy. BMC Nephrol. 2011;12:61.", "ArticleIdList": ["PMC3261102", "22081953"]}, {"Citation": "Bocci V Biological and clinical effects of ozone. Has ozone therapy a future in medicine? Br J Biomed Sci. 1999;56:270\u2013279.", "ArticleIdList": ["10795372"]}, {"Citation": "Notarangelo L, Casanova JL, Fischer A, et al. Primary immunodeficiency diseases: an update. J Allergy Clin Immunol. 2004;114:677\u2013687.", "ArticleIdList": ["15356576"]}, {"Citation": "Paulesu L, Luzzi E, Bocci V. Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-alpha) on human leucocytes. Lymphokine Cytokine Res. 1991;10:409\u2013412.", "ArticleIdList": ["1768744"]}, {"Citation": "Diaz-Luis J, Menendez-Cepero S, Diaz-Luis A, Ascanio-Garcia Y. In vitro effect of ozone in phagocytic function of leucocytes in peripheral blood. J Ozone Ther. 2015 doi: 10.7203/jo3t.1.1.2015.10627."}, {"Citation": "Frush BW, Li Z, Stiles JV, et al. Ozone primes alveolar macrophage-derived innate immunity in healthy human subjects. J Allergy Clin Immunol. 2016;138:1213\u20131215.e1.", "ArticleIdList": ["PMC5056795", "27325435"]}, {"Citation": "Yamanel L, Kaldirim U, Oztas Y, et al. Ozone therapy and hyperbaric oxygen treatment in lung injury in septic rats. Int J Med Sci. 2011;8:48\u201355.", "ArticleIdList": ["PMC3020392", "21234269"]}, {"Citation": "Valdenassi L, Franzini M, Ricevuti G, Rinaldi L, Galoforo AC, Tirelli U. Potential mechanisms by which the oxygen-ozone (O2-O3) therapy could contribute to the treatment against the coronavirus COVID-19. Eur Rev Med Pharmacol Sci. 2020;24:4059\u20134061.", "ArticleIdList": ["32374009"]}, {"Citation": "Promoter of the study NUOVA FIO (Italian Oxygen-Ozone Federation), Marini S, Maggiorotti M, et al. Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study. J Biol Regul Homeost Agents. 2020;34:757\u2013766.", "ArticleIdList": ["32462858"]}, {"Citation": "Mart\u00ednez-S\u00e1nchez G, Schwartz A, Donna VD. Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (Basel) 2020;9:389.", "ArticleIdList": ["PMC7278582", "32384798"]}, {"Citation": "Zheng Z, Dong M, Hu K. A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19. J Med Virol. 2020;92:2348\u20132350.", "ArticleIdList": ["PMC7280732", "32437014"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Isidoro T, Vil\u00e1s F. Potential role of oxygen-ozone therapy in treatment of COVID-19 pneumonia. Am J Case Rep. 2020;21:e925849.", "ArticleIdList": ["PMC7476746", "32804917"]}, {"Citation": "Franzini M, Valdenassi L, Ricevuti G, et al. Oxygen-ozone (O(2)-O(3)) immunoceutical therapy for patients with COVID-19. Preliminary evidence reported. Int Immunopharmacol. 2020;88:106879.", "ArticleIdList": ["PMC7414302", "32795898"]}, {"Citation": "Wu J, Tan CS, Yu H, et al. Recovery of four COVID-19 patients via ozonated autohemotherapy. Innovation (Camb) 2020;1:100060.", "ArticleIdList": ["PMC7609231", "33169118"]}, {"Citation": "Hern\u00e1ndez A, Vi\u00f1als M, Pablos A, et al. Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study. Int Immunopharmacol. 2021;90:107261.", "ArticleIdList": ["PMC7833586", "33310665"]}, {"Citation": "Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726\u2013732.", "ArticleIdList": ["20335313"]}, {"Citation": "Rakness K, Gordon G, Langlais B, et al. Guideline for measurement of ozone concentration in the process gas from an ozone generator. Ozone Sci Eng. 1996;18:209\u2013229."}, {"Citation": "Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30:1772\u20131777.", "ArticleIdList": ["12163791"]}, {"Citation": "van Meenen DMP, van der Hoeven SM, Binnekade JM, et al. Effect of on-demand vs routine nebulization of acetylcysteine with salbutamol on ventilator-free days in intensive care unit patients receiving invasive ventilation: a randomized clinical trial. JAMA. 2018;319:993\u20131001.", "ArticleIdList": ["PMC5885882", "29486489"]}, {"Citation": "Wu J, Tan C, Yu H, et al. Case report: recovery of one ICU-acquired COVID-19 patient via ozonated autohemotherapy. SSRN. 2020 doi: 10.2139/ssrn.3561379."}, {"Citation": "Thorp JA, Hollonbeck SA, Viglione DD, et al. Novel therapy for COVID-19 does intravenous ozonated-saline affect blood and tissue oxygenation? J Gynecol Res Obstet. 2020;6:046\u2013050."}, {"Citation": "Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.", "ArticleIdList": ["PMC7190011", "32217556"]}, {"Citation": "Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708\u20131720.", "ArticleIdList": ["PMC7092819", "32109013"]}, {"Citation": "McFadyen JD, Stevens H, Peter K. The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127:571\u2013587.", "ArticleIdList": ["PMC7386875", "32586214"]}, {"Citation": "Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145\u2013147.", "ArticleIdList": ["PMC7146714", "32291094"]}, {"Citation": "Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428\u2013430.", "ArticleIdList": ["PMC7129165", "32145190"]}, {"Citation": "Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.", "ArticleIdList": ["PMC7159299", "31986264"]}, {"Citation": "Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451\u20132460.", "ArticleIdList": ["32412710"]}, {"Citation": "Zaky S, Fouad EA, Kotb HI. The effect of rectal ozone on the portal vein oxygenation and pharmacokinetics of propranolol in liver cirrhosis (a preliminary human study) Br J Clin Pharmacol. 2011;71:411\u2013415.", "ArticleIdList": ["PMC3045550", "21284700"]}, {"Citation": "Scassellati C, Ciani M, Galoforo AC, Zanardini R, Bonvicini C, Geroldi C. Molecular mechanisms in cognitive frailty: potential therapeutic targets for oxygen-ozone treatment. Mech Ageing Dev. 2020;186:111210.", "ArticleIdList": ["31982474"]}, {"Citation": "Peralta C, Le\u00f3n OS, Xaus C, et al. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Radic Res. 1999;31:191\u2013196.", "ArticleIdList": ["10499775"]}, {"Citation": "Sancak EB, Turk\u00f6n H, \u00c7ukur S, et al. Major ozonated autohemotherapy preconditioning ameliorates kidney ischemia-reperfusion injury. Inflammation. 2016;39:209\u2013217.", "ArticleIdList": ["26282390"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "11", "Day": "7", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "6", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "11", "Day": "6", "Hour": "5", "Minute": "3"}, {"Year": "2023", "Month": "10", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["37929510", "PMC10715328", "10.4103/2045-9912.385439", "MedGasRes_2024_14_2_67_385439"]}}], "PubmedBookArticle": []}